EUVIMEDEUVIMED entdecken
Crossref

Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours

Amelia Barcellini, Roberto Rordorf, Veronica Dusi, Giulia Fontana iD, Antonella Pepe, Alessandro Vai, Sandra Schirinzi, Viviana Vitolo, Ester Orlandi, Alessandra Greco

Strahlentherapie und Onkologie · 2024

DOI: 10.1007/s00066-024-02270-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Strahlentherapie und Onkologie, 2024. Verfasst von Amelia Barcellini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, 27100, Pavia, Italy. Hauptthemen laut MEDLINE: Heavy Ion Radiotherapy, Heart Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Modern photon radiotherapy effectively spares cardiac structures more than previous volumetric approaches. Still, it is related to non-negligible cardiac toxicity due to the low-dose bath of surrounding normal tissues. However, the dosimetric advantages of particle radiotherapy make it a promising treatment for para- and intra-cardiac tumours. In the current short report, we evaluate the cardiac safety profile of carbon ion radiotherapy (CIRT) for radioresistant intra- and para-cardiac malignancies in a real-world setting. METHODS: We retrospectively analysed serum biomarkers (TnI, CRP and NT-proBNP), echocardiographic, and both 12-lead and 24-hour Holter electrocardiogram (ECG) data of consecutive patients with radioresistant intra- and para-cardiac tumours irradiated with CIRT between June 2019 and September 2022. In the CIRT planning optimization process, to minimize the delivered doses, we contoured and gave a high priority to the cardiac substructures. Weekly re-evaluative 4D computed tomography scans were carried out throughout the treatment. RESULTS: A total of 16 patients with intra- and para-cardiac localizations of radioresistant tumours were treated up to a total dose of 70.4 Gy relative biological effectiveness (RBE) and a mean heart dose of 2.41 Gy(RBE). We did not record any significant variation of the analysed serum biomarkers after CIRT nor significant changes of echocardiographic features, biventricular strain, or 12-lead and 24-hour Holter ECG parameters during 6 months of follow-up. CONCLUSION: Our pilot study suggests that carbon ion radiotherapy is a promising radiation technique capable of sparing off-target side effects at the cardiac level. A larger cohort, long-term follow-up and further prospective studies are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heavy Ion RadiotherapyHeart NeoplasmsHumansPilot ProjectsMaleFemaleAgedMiddle AgedRetrospective StudiesHeartRadiation InjuriesElectrocardiography, AmbulatoryAged, 80 and overEchocardiographyRadiotherapy DosageBiomarkersPeptide FragmentsNatriuretic Peptide, Brain

Stichwörter der Autor:innen

CIRTCardiac toxicityEchocardiographic toxicity featuresRadioresistant thoracic tumoursSerum toxicity biomarkers

Substanzen

BiomarkersPeptide FragmentsNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Department of Internal Medicine and Therapeutics, University of Pavia, 27100, Pavia, Italy.
  • Radiation Oncology Unit, Clinical Department, CNAO National Center for Oncological Hadrontherapy, 27100, Pavia, Italy.
  • Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy.
  • Arrhythmia and Electrophysiology Unit, Fondazione IRCCS Policlinico San Matteo, 27100, Pavia, Italy.
  • Division of Cardiology, Department of Medical Sciences, University of Turin, 10126, Torino, Italy.
  • Clinical Department, CNAO National Center for Oncological Hadrontherapy, Via Erminio Borloni 1, 27100, Pavia, Italy. giulia.fontana@cnao.it.

ORCID-Profile: Giulia Fontana

Zitieren

APA

Barcellini, A., Rordorf, R., Dusi, V., Fontana, G., Pepe, A., Vai, A., Schirinzi, S., Vitolo, V., Orlandi, E., & Greco, A. (2024). Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-024-02270-2

Vancouver

Barcellini A, Rordorf R, Dusi V, Fontana G, Pepe A, Vai A, et al. Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours. Strahlentherapie und Onkologie. 2024. doi:10.1007/s00066-024-02270-2

BibTeX
@article{Barcellini2024,
  author = {Barcellini, Amelia and Rordorf, Roberto and Dusi, Veronica and Fontana, Giulia and Pepe, Antonella and Vai, Alessandro and Schirinzi, Sandra and Vitolo, Viviana and Orlandi, Ester and Greco, Alessandra},
  title = {Pilot study to assess the early cardiac safety of carbon ion radiotherapy for intra- and para-cardiac tumours},
  journal = {Strahlentherapie und Onkologie},
  year = {2024},
  doi = {10.1007/s00066-024-02270-2}
}
Kostenlos starten →